ESMO 2023: Immunotherapy Advancements in Bladder Cancer - Episode 6

Enfortumab Vedotin and the Role of ADCs in Bladder Cancer

, , ,

Bladder cancer specialists discuss enfortumab vedotin and the role of antibody-drug conjugates in the treatment landscape.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    x